Authors: Colbern, GT Hiller, AJ Musterer, RS Pegg, E Henderson, IC Working, PK

Citation: Gt. Colbern et al., Significant increase in antitumor potency of doxorubicin HCl by its encapsulation in pegylated liposomes, J LIPOS RES, 9(4), 1999, pp. 523-538

Authors: Newman, MS Colbern, GT Working, PK Engbers, C Amantea, MA

Citation: Ms. Newman et al., Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice (vol 43, pg 1, 1999), CANC CHEMOT, 43(6), 1999, pp. 524-524

Authors: Newman, MS Colbern, GT Working, PK Engbers, C Amantea, MA

Citation: Ms. Newman et al., Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice, CANC CHEMOT, 43(1), 1999, pp. 1-7

Authors: Colbern, GT Hiller, AJ Musterer, RS Working, PK Henderson, IC

Citation: Gt. Colbern et al., Antitumor activity of Herceptin (R) in combination with STEALTH (R) liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model, J INORG BIO, 77(1-2), 1999, pp. 117-120

Authors: Colbern, GT Dykes, DJ Engbers, C Musterer, R Hiller, A Pegg, E Saville, R Weng, S Luzzio, M Uster, P Amantea, M Working, PK

Citation: Gt. Colbern et al., Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: Pharmacokinetics and antitumor activity in HT29 colon tumor xenografts, CLIN CANC R, 4(12), 1998, pp. 3077-3082